Is the Stock Market on a Collision Course With History? More Than a Century of Data Tells the Tale.
The current bull market marks only the third time in history the S&P 500's Shiller P/E has surpassed 38, the other two being ...
Apple Inc. (NASDAQ:AAPL) is Bridge Creek Capital Management LLC’s Largest Position
Bridge Creek Capital Management LLC decreased its stake in Apple Inc. (NASDAQ:AAPL – Free Report) by 2.9% in the fourth ...
What is Zacks Research’s Estimate for BMRN Q3 Earnings?
Zacks Research raised their Q3 2025 earnings estimates for BioMarin Pharmaceutical in a report released on Monday, February ...
Analog Devices, Inc. (ADI) Beats Q1 Estimates, AI Expansion Strengthens Growth Outlook
We recently published a list of Top 9 AI News and Ratings Sending Shockwaves. In this article, we are going to take a look at ...
Palantir: The Market Has Lost Its Mind
Palantir’s strong growth doesn’t justify its high valuation. Read why PLTR stock is overvalued, with a fair value of $49.95 ...
W Advisors LLC Sells 1,498 Shares of NVIDIA Co. (NASDAQ:NVDA)
W Advisors LLC decreased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 8.6% in the 4th quarter, ...
Patrick M Sweeney & Associates Inc. Decreases Stock Holdings in NVIDIA Co. (NASDAQ:NVDA)
Patrick M Sweeney & Associates Inc. decreased its holdings in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.7% in the fourth ...
Strategic Financial Concepts LLC Acquires New Shares in PepsiCo, Inc. (NASDAQ:PEP)
Strategic Financial Concepts LLC acquired a new stake in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) during the 4th ...
FY2027 Earnings Estimate for Celsius Issued By Roth Capital
Equities researchers at Roth Capital issued their FY2027 earnings estimates for Celsius in a research report issued to ...
Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a report issued on Wednesday,Benzinga reports. They currently have a $64.00 price ...
Stoke Therapeutics’ (STOK) “Buy” Rating Reiterated at Chardan Capital
Chardan Capital reissued their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $24 ...
Comparing SolarBank (SUUN) and Its Rivals
SolarBank (NASDAQ:SUUN – Get Free Report) is one of 29 public companies in the “Electric & other services combined” industry, but how does it contrast to its rivals? We will compare SolarBank to ...